Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation
Authors:
Open Access
- 9 April 2008
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 115 (6) , 681-688
Abstract
Objective Outcome investigations of prenatal maternal depression and psychotropic exposure rely extensively on maternal retrospective recall. This study compared postnatal recall to prospective documentation of illness and medication exposures.Design Prospective cohort and retrospective case–control studies.Setting Emory Women’s Mental Health Program (prospective study) and Emory University Department of Psychology (retrospective study).Sample A total of 164 women who participated in both the prospective and retrospective studies.Methods Women with a history of mental illness were followed during pregnancy for prospective prenatal assessments of depression and medication exposures. At 6 months postpartum, some of these women also participated in a retrospective study during which they were asked to recall prenatal depression and medication use. Agreement between prospective and retrospective documentation of exposures was analysed.Main outcome measures Occurrence of maternal depression during pregnancy and maternal use of pharmacological agents during pregnancy.Results There was only moderate agreement (k = 0.42) in prospective versus retrospective reporting of prenatal depression. Positive predictive value for recalling depression was 90.4%; however, negative predictive value for denying depression was only 53.8%. Participants accurately recalled psychotropic use but significantly underreported use of nonpsychotropic medications.Conclusions Studies using retrospective data collection may be susceptible to systematic recall bias with underreporting of maternal depression and use of nonpsychotropic agents during pregnancy.Keywords
This publication has 45 references indexed in Scilit:
- Lamotrigine in bipolar disorder: efficacy during pregnancyBipolar Disorders, 2008
- Association between antenatal depression and low birthweight in a developing countryActa Psychiatrica Scandinavica, 2007
- Risks Associated With Selective Serotonin Reuptake Inhibitors in PregnancyObstetrics & Gynecology, 2005
- Health, Sociodemographic Data, and Pregnancy Outcome in Women With Antepartum Depressive SymptomsObstetrics & Gynecology, 2004
- The impact of depression and fluoxetine treatment on obstetrical outcomeArchives of Women's Mental Health, 2004
- Maternal antenatal anxiety and children's behavioural/emotional problems at 4 yearsThe British Journal of Psychiatry, 2002
- Depressed withdrawn and intrusive mothers’ effects on their fetuses and neonatesInfant Behavior and Development, 2001
- Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancies of lower social class women.Health Psychology, 2000
- Maternal reproductive history: a registry based comparison of previous pregnancy data derived from maternal recall and data obtained during the actual pregnancyActa Obstetricia et Gynecologica Scandinavica, 2000
- Biases of attention and memory in disorders of anxiety and depressionClinical Psychology Review, 1990